| A new 10 minute test to determine whether
| |
| | speed up the research on preventive
|
| a patient has Alzheimer's disease is the
| |
| | therapies. Whether those therapies are
|
| CANTAB Paired Associates Learning Test or
| |
| | drug therapies, diet, or other
|
| PAL. This test is opening new doors of
| |
| | techniques, Scientist will now have
|
| possibilities for the treatment of
| |
| | living subjects who can undergo stringent
|
| Alzheimer's by pinpointing with 98%
| |
| | test to determine the true effects of
|
| accuracy whether a person has Alzheimer's
| |
| | these therapies.
|
| disease.
| |
| | The results of the study suggests that
|
| An early concrete diagnosis of this
| |
| | impaired performance on one
|
| dreaded disease may open the door for new
| |
| | neuropsychological test, CANTAB Paired
|
| drugs that can be tested on live
| |
| | Associates Learning (PAL), might serve as
|
| subjects. The test is said to be able to
| |
| | a marker for pre-clinical Alzheimer's
|
| make a distinction between those patients
| |
| | disease. PAL is a stringent test for
|
| who are suffering from Alzheimer's and
| |
| | episodic memory.
|
| those individuals who have no
| |
| | This PAL test assesses visual memory and
|
| neuropsychiatric disorder.
| |
| | the ability of the patient to learn new
|
| The accuracy of this test is said to be
| |
| | things. This test will prove a useful
|
| higher than any of the other Alzheimer's
| |
| | tool for assessing and making
|
| test like the FAST, or MME results. The
| |
| | determinations on whether a patient with
|
| CANTAB PAL test is reported at a 98%
| |
| | questionable dementia is suffering from
|
| accuracy rate compared to the other test
| |
| | Alzheimer's disease, age-related memory
|
| whose accuracy is 90%. Professor
| |
| | loss or another types of dementia.
|
| Robbins and Dr. Barbara Sahakian are the
| |
| | Overview of the PAL Test
|
| developers of the test.
| |
| |
|
| "This test is more specific to
| |
| | 1. The test is administered on computer
|
| Alzheimer's patients", states Dr.
| |
| | screens.
|
| Sahakia, "The CANTAB PAL can test those
| |
| | 2. There are boxes that are displayed on
|
| areas of the brain that are first
| |
| | the screen.
|
| affected by Alzheimer's disease".
| |
| | 3. These boxes are opened in a random
|
| Since there is no cure for Alzheimer's
| |
| | order.
|
| disease, the only alternative is for the
| |
| | 4. One or more of the boxes will display
|
| patient to receive an early diagnosis in
| |
| | a pattern.
|
| hopes that the disease can be treated.
| |
| | 5. The patterns are then displayed in the
|
| It is estimated that 2-5% of people over
| |
| | middle of the screen, one at a time
|
| 65 years of age and up to 20% of those
| |
| | 6. The patient is asked to touch the box
|
| over 85 years of age suffer from
| |
| | where the pattern was originally located.
|
| Alzheimer's disease.
| |
| | If the subject makes an error, the
|
| Early detection and diagnosis are
| |
| | patterns are presented again to remind
|
| critical factors for the effective
| |
| | the subject of the locations. The
|
| treatment of Alzheimer's Disease. This
| |
| | difficulty level increases throughout the
|
| new test may someday provide the link
| |
| | test. In the clinical mode, the number of
|
| from early detection to total cure. If
| |
| | patterns increases from one to eight. At
|
| there is a 98% accuracy rate, then
| |
| | the eighth level, test providers admit
|
| pharmacological evaluations of victims of
| |
| | that it is a challenge even for those
|
| the disease will be more reliable.
| |
| | individuals who show no signs of dementia
|
| Early detection of Alzheimer's can also
| |
| | to achieve a perfect score.
|
